LIGEN Trademark

Trademark Overview


On Wednesday, November 23, 2022, a trademark application was filed for LIGEN with the United States Patent and Trademark Office. The USPTO has given the LIGEN trademark a serial number of 79360498. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by Dompe' farmaceutici Spa. The LIGEN trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration sof...

Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, softwar...
ligen

General Information


Serial Number79360498
Word MarkLIGEN
Filing DateWednesday, November 23, 2022
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7383355
Registration DateTuesday, May 14, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements


Description of MarkThe mark consists of the word "LIGEN" with a red dot between the L and I. The "LI" lettering appears in red, while "GEN" is in grey. To the left is a cube design in grey with a red sphere in the center, the left side of which creates a red "L" and "I," while the right side creates a grey "G". White indicates transparent matter and is not claimed as a feature of the mark.
Goods and ServicesDownloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models in the field of healthcare
Pseudo MarkLG LIGEN
Indication of Colors claimedThe color(s) red and grey is/are claimed as a feature of the mark.
Goods and ServicesSoftware as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDompe' farmaceutici Spa
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameDompe' farmaceutici Spa
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameDompe' farmaceutici Spa
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events


Event DateEvent Description
Thursday, January 19, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, September 6, 2023ASSIGNED TO EXAMINER
Wednesday, September 6, 2023NON-FINAL ACTION WRITTEN
Thursday, September 7, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 25, 2023REFUSAL PROCESSED BY MPU
Monday, September 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 17, 2023REFUSAL PROCESSED BY IB
Wednesday, January 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 11, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, January 11, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, January 11, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 11, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, January 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER